Navigation Links
Amsterdam Molecular Therapeutics to Release H1 2007 Results on August 29, 2007
Date:8/22/2007

AMSTERDAM, August 22 /PRNewswire-FirstCall/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, today announced that it will release its financial results for the first six months of 2007 on Wednesday, August 29, 2007 at 8 am Central European Time (CET).

To discuss these results, the Company will conduct a conference call at 10 am CET. Netherlands Dial In: +31-800-949-4517 (toll free); US Dial In: +1-866-291-4166 (toll free); UK Dial In: +44-207-107-0611.

To listen to the conference call live via the internet, visit the investor relations portion of the AMT website at http://www.amtbv.com. Please go to the website 15 minutes prior to the call to register, download and install the necessary audio software.

About Amsterdam Molecular Therapeutics

AMT has a unique gene therapy platform that to date appears to circumvent many if not all of the obstacles that have prevented gene therapy to become a mainstay of clinical medicine. Using adeno-associated viral (AAV) vectors as the delivery vehicle of choice for therapeutic genes, the company has been able to design and validate what is probably the first stable and scalable AAV production platform. As such, AMT's proprietary platform holds tremendous promise for thousands of rare (orphan) diseases that are caused by one faulty gene. AMT currently has a product pipeline with six products at different stages of development.


'/>"/>
SOURCE Amsterdam Molecular Therapeutics B.V
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Detect Single Nucleotide Sequence Changes with Mx4000 Molecular Beacon Allelic Discrimination Kits
2. Genotyping Single Nucleotide Polymorphisms with Molecular Beacons
3. New Protocols for Isolating High- Molecular-Weight Genomic DNA
4. HSVision Molecular Beacon Detection Module Rapidly Detects Herpes Simplex Virus DNA
5. Molecular Biology:Easy Dephosphorylation and Rapid DNA Ligation
6. Isolation of Low Molecular Weight Digestion Products of the Human Platelet Thromboxane A2 Receptor, Rev A
7. Quantitation of GAD67 Gene Expression in Prefrontal Cortex of Schizophrenia Patients Using the iCycler iQ Detection System and Molecular Beacons, Rev A
8. Measurement of proteasome inhibition in live cells in Molecular Devices microplate fluorometers
9. Measurement of Molecular Beacons in the SpectraMax Gemini Spectrofluorometer (MaxLine Application Note #36)
10. Kodak in vivo imaging system: precise coregistration of molecular imaging with anatomical X-ray imaging in animals
11. Near Infrared Technology and Optical Agents For Molecular Imaging

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)... YORK, Nov. 19 NeoStem, ...as sent the following letter to its shareholders, ...0, 2009, of China Biopharmaceuticals Holdings, Inc... based in the People,s Republic of China. The merg...hou Eyre Pharmaceutical Co. Ltd., CHBP,s primary o...
(Date:11/19/2009)... MALVERN, Pa. and WALTHAM, Mass., Nov. 19 /PRNewsw...sion Resources find that the leading driver of ant...e is broad-spectrum activity against gram-positive...f organisms that can cause nosocomial pneumonia, s...primarily for agents that provide appropriate cove...
(Date:11/19/2009)...TREAL, Nov. 19 /PRNewswire/ - Aegera Therapeutics ...nt in a randomized Phase 2B study of AEG35156, a t...ment for multiple oncology indications. ,, The ...Study of the X-Linked Inhibitor of Apoptosis (XIAP...h-dose Cytarabine and Idarubicin in AML Following ...
(Date:11/19/2009)... World,s Top Gene Synthesis Companies F... to Coordinate Best Practices in Risk Reduction ,...ldwide Gene Synthesis Capacity , ...orld’s leading gene synthesis companies toda...n screening protocol to promote biosecurity in the...
Breaking Biology Technology:NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 3Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 3World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 4
...5 BSP Ltd.,( http://www.bsp.co.il/pressall.asp ),...tems for non-invasive diagnosis and monitoring of ...perQ(TM) Stress System in the US during,the 57th A...TM) is cutting-edge technology implemented in an i...able, low-cost and risk free,cardiac monitoring fo...
...rosoft technology over competitors for its ease of...abilities., REDMOND, Wash., March 25 Microsoft C...cted Microsoft Dynamics AX 4.0,to speed and integr...,company,s compliance with the Sarbanes-Oxley Act ...uthorities, including the Food and Drug,Administra...
...25 /Xinhua-PRNewswire-FirstCall/ -- China,Biologic... or "the,Company"), one of the leading plasma-base...c of China ("PRC"), today announced that one of it...s B Immunoglobulin", was listed,in the National To...rganized and executed by The Ministry of,Science a...
Other Biology Technology:World Debut for BSP's HyperQ Stress System: 57th Annual American College of Cardiology Meeting 2008 2Bioscience Company Chooses Microsoft Dynamics AX to Improve Support for Compliance With Industry Rules 2Bioscience Company Chooses Microsoft Dynamics AX to Improve Support for Compliance With Industry Rules 3Bioscience Company Chooses Microsoft Dynamics AX to Improve Support for Compliance With Industry Rules 4Bioscience Company Chooses Microsoft Dynamics AX to Improve Support for Compliance With Industry Rules 5China Biologic Products Announces One of Its R&D Projects Has Been Listed In National Torch Plan 2China Biologic Products Announces One of Its R&D Projects Has Been Listed In National Torch Plan 3
(Date:11/19/2009)... new study of maize has identified thousands of di...f the genome. New techniques may allow breeders an...ntify desirable traits and create new varieties th... in the Nov. 19 issue of Science , the researcher...ave identified the first map of haplotypes sets o...
(Date:11/19/2009)...vember 19, 2009 A team led by scientists at The Sc...link between insulina hormone long associated with...esand core body temperature. While much research h...n the 1920s, this is the first time the hormone ha...perature regulation. , The paper was published r...
(Date:11/19/2009)... A new statistical technique developed by research...s to scan a genome for specific gene-regulatory re...evant transcription factors. The technique has bee...e and the fruit fly genome. , "Our statistical ap...ches, and is especially useful for investigating g...
Breaking Biology News(10 mins):New map of variation in maize genetics holds promise for developing new varieties 2Scripps research scientists find new link between insulin and core body temperature 2Scripps research scientists find new link between insulin and core body temperature 3Scripps research scientists find new link between insulin and core body temperature 4Technique finds gene regulatory sites without knowledge of regulators 2Allegheny Medical Announces Launch of the New AlleghenyMedical com 60211 1Allegheny Medical Announces Launch of the New AlleghenyMedical com 60211 2Allegheny Medical Announces Launch of the New AlleghenyMedical com 60211 3IN Compass Health 26apos 3Bs Hospitalist Team at Morton Plant Wins First BayCare Quality Award 60208 1IN Compass Health 26apos 3Bs Hospitalist Team at Morton Plant Wins First BayCare Quality Award 60208 2IN Compass Health 26apos 3Bs Hospitalist Team at Morton Plant Wins First BayCare Quality Award 60208 3IN Compass Health 26apos 3Bs Hospitalist Team at Morton Plant Wins First BayCare Quality Award 60208 4Resounding Health Receives Small Business Innovation Research Award from the National Institutes of Health 60205 1Resounding Health Receives Small Business Innovation Research Award from the National Institutes of Health 60205 2Resounding Health Receives Small Business Innovation Research Award from the National Institutes of Health 60205 3
...an rubber: spider silk is unsurpassed in its expan...ider silk would be an ideal material for a large v...researchers are thus interested in learning the sp...am lead by Thomas Scheibel at the Technical Univer...rection. As they report in the journal Angewandte ...
...s in an enhanced long-term memory, researchers rep..., published by Cell Press. These findings point to...to treat memory loss, according to the researchers...ncreases levels of a natural memory-blocking prote... gene showed improved performance in classical beh...
...search Hospital have discovered previously unsuspe... pediatric acute lymphoblastic leukemia (ALL), the... only suggests novel methods for treating pediatri...ication of unsuspected mutations in adult cancers.... cells that normally develop into immune system ce...
Other Biology News:Fascinating spider silk 2Mutation improves memory, may lead to memory-enhancing pill 2Mutation improves memory, may lead to memory-enhancing pill 3Major gene study uncovers secrets of leukemia 2Major gene study uncovers secrets of leukemia 3
... the 9, 10, 12, and 13 positions. It is intended f...ion of 13(S)-HODE by GC- or LC-mass spectrometry. ...cid with plant and mammalian lipoxygenases. It has... to the endothelium at concentrations around 1 &#x...
pcDNA4/His A B & C from Invitrogen
Adaptor Hind III - Sma I from Takara Mirus Bio
Adaptor Sal I - Sma I from Takara Mirus Bio
Biology Products: